Cme Group (CME) EPS (Weighted Average and Diluted): 2009-2025
Historic EPS (Weighted Average and Diluted) for Cme Group (CME) over the last 17 years, with Sep 2025 value amounting to $2.49.
- Cme Group's EPS (Weighted Average and Diluted) fell 0.40% to $2.49 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.32, marking a year-over-year increase of 8.52%. This contributed to the annual value of $9.67 for FY2024, which is 9.14% up from last year.
- Latest data reveals that Cme Group reported EPS (Weighted Average and Diluted) of $2.49 as of Q3 2025, which was down 11.39% from $2.81 recorded in Q2 2025.
- Over the past 5 years, Cme Group's EPS (Weighted Average and Diluted) peaked at $2.81 during Q2 2025, and registered a low of $1.42 during Q2 2021.
- Moreover, its 3-year median value for EPS (Weighted Average and Diluted) was $2.42 (2024), whereas its average is $2.41.
- Per our database at Business Quant, Cme Group's EPS (Weighted Average and Diluted) soared by 124.35% in 2021 and then decreased by 27.52% in 2022.
- Cme Group's EPS (Weighted Average and Diluted) (Quarterly) stood at $1.69 in 2021, then increased by 4.14% to $1.76 in 2022, then grew by 27.27% to $2.24 in 2023, then climbed by 7.14% to $2.40 in 2024, then fell by 0.40% to $2.49 in 2025.
- Its last three reported values are $2.49 in Q3 2025, $2.81 for Q2 2025, and $2.62 during Q1 2025.